Navigation Links
Strong Social Connections Needed for Biotech to Grow in Los Angeles
Date:9/16/2009

CLAREMONT, Calif., Sept. 16 /PRNewswire/ -- Stronger connections among businesses, universities and, most importantly, people are necessary if the biotechnology industry is going to survive and thrive in Los Angeles, according to a new study by Professor Steven Casper at Keck Graduate Institute (KGI).

While Boston, San Diego and San Francisco have thriving biotechnology clusters, regions like Los Angeles, Chicago and New York City have failed despite the presence of strong research universities and the availability of venture capital, two keys factors in the development of biotechnology clusters.

Casper, KGI's Henry E. Riggs Professor of Management and director of the Master of Bioscience program, concluded after an 18-month study that what's missing in those cities is a rich social network connecting scientists, entrepreneurs, managers and venture capitalists who are in the business of starting companies.

"Government can make the marketplace of ideas transparent and open," says Casper. "Local governments can offer tax incentives. But government can't create social networks."

After reviewing data on deal-making, alliances and career moves in his study ("The Marketplace for Ideas: Can Los Angeles Build a Successful Biotechnology Cluster?"), Casper developed three possible scenarios in which biotechnology clusters might take root and grow in Los Angeles:

  • Los Angeles area biotechnology firms could tie into the rich social network within the biomedical device industry that exists in Orange County, similar to what biotechnology industries in San Francisco did with the Silicon Valley's semi-conductor industry.
  • Caltech in Pasadena could serve as a catalyst for the biotechnology industry much like MIT has done in Boston. But while Caltech is the most likely university, it has no business school, there is no medical school in the vicinity and its mission is less entrepreneurial.
  • Los Angeles could take advantage of the biotechnology start-ups that are developing along the Hwy 101 corridor to the north. Amgen, the most successful company in the region with about 8,000 employees, is located in Thousand Oaks. However, Casper found the turnover rate at Amgen is half the industry norm. As a result, the occasional start-up has a hard time attracting talent.

Casper's research was funded by an $84,000 grant from the John Randolph Haynes and Dora Haynes Foundation.

KGI BACKGROUND

Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education through its Master of Bioscience (MBS) degree program and its PhD program in Applied Life Sciences. Using team-based learning and real-world projects, KGI's innovative curriculum seamlessly combines applied life sciences, bioengineering, bioethics and business management. KGI also has a robust research program concentrating on the translation of basic discoveries in the life sciences into applications that can benefit society. KGI is a member of The Claremont Colleges, located in Claremont, California.

Keck Graduate Institute of Applied Life Sciences is dedicated to education and research aimed at translating into practice, for the benefit of society, the power and potential of the life sciences.


'/>"/>
SOURCE Keck Graduate Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Analysis confirms that nano-related research has strong multidisciplinary roots
2. Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
3. Muscular protein bond -- strongest yet found in nature
4. STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
5. Information warfare in the 21st century: Ideas are sometimes stronger than bombs
6. New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma
7. Web of Science(R) Renewals Remain Strong Despite Tough Economic Climate
8. Information warfare in the 21st century: Ideas are sometimes stronger than bombs
9. China Biologic Products Announces Strong First Quarter 2009 Results
10. Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy
11. Shire begins the year with a strong performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... October 10, ... ... risk management, technological innovation and business process optimization firm for the life sciences ... the BoxWorks conference in San Francisco. , The presentation, “Automating GxP ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):